BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18976668)

  • 1. Pathogenic activation of receptor tyrosine kinases in mammalian membranes.
    He L; Hristova K
    J Mol Biol; 2008 Dec; 384(5):1130-42. PubMed ID: 18976668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific inhibition of a pathogenic receptor tyrosine kinase by its transmembrane domain.
    He L; Shobnam N; Hristova K
    Biochim Biophys Acta; 2011 Jan; 1808(1):253-9. PubMed ID: 20713021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and forster resonance energy transfer suggest weak interactions between fibroblast growth factor receptor 3 (FGFR3) transmembrane domains in the absence of extracellular domains and ligands.
    Li E; You M; Hristova K
    Biochemistry; 2005 Jan; 44(1):352-60. PubMed ID: 15628877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pathogenic cysteine mutations on FGFR3 transmembrane domain dimerization in detergents and lipid bilayers.
    You M; Spangler J; Li E; Han X; Ghosh P; Hristova K
    Biochemistry; 2007 Oct; 46(39):11039-46. PubMed ID: 17845056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput selection of transmembrane sequences that enhance receptor tyrosine kinase activation.
    He L; Hoffmann AR; Serrano C; Hristova K; Wimley WC
    J Mol Biol; 2011 Sep; 412(1):43-54. PubMed ID: 21767549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. delta-Opioid receptor-stimulated Akt signaling in neuroblastoma x glioma (NG108-15) hybrid cells involves receptor tyrosine kinase-mediated PI3K activation.
    Heiss A; Ammer H; Eisinger DA
    Exp Cell Res; 2009 Jul; 315(12):2115-25. PubMed ID: 19362548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suitable transmembrane domain significantly increase the surface-expression level of Fc(epsilon)RIalpha in 293T cells.
    Qiao C; Guo L; Sun J; Li Y; Lin Z; Lv M; Feng J; Shen B
    J Biotechnol; 2009 Feb; 139(3):195-202. PubMed ID: 19110016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of the integral membrane proteins EGFR and FGFR3 in anti-apoptotic Chinese hamster ovary cell lines.
    Ohsfeldt E; Huang SH; Baycin-Hizal D; Kristoffersen L; Le TM; Li E; Hristova K; Betenbaugh MJ
    Biotechnol Appl Biochem; 2012; 59(3):155-62. PubMed ID: 23586824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of the effects of mutations on receptor tyrosine kinase (RTK) activation in mammalian cells.
    He L; Hristova K
    Methods Mol Biol; 2015; 1233():81-7. PubMed ID: 25319891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGFR3 dimer stabilization due to a single amino acid pathogenic mutation.
    Li E; You M; Hristova K
    J Mol Biol; 2006 Feb; 356(3):600-12. PubMed ID: 16384584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assays to measure the activation of membrane tyrosine kinase receptors: focus on cellular methods.
    Minor LK
    Curr Opin Drug Discov Devel; 2003 Sep; 6(5):760-5. PubMed ID: 14579525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin receptor kinase-independent signaling via tyrosine phosphorylation of phosphatase PHLPP1.
    Zhang M; Riedel H
    J Cell Biochem; 2009 May; 107(1):65-75. PubMed ID: 19277985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A New Method to Study Heterodimerization of Membrane Proteins and Its Application to Fibroblast Growth Factor Receptors.
    Del Piccolo N; Sarabipour S; Hristova K
    J Biol Chem; 2017 Jan; 292(4):1288-1301. PubMed ID: 27927983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells.
    Tao RH; Maruyama IN
    J Cell Sci; 2008 Oct; 121(Pt 19):3207-17. PubMed ID: 18782861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The extracellular domain of fibroblast growth factor receptor 3 inhibits ligand-independent dimerization.
    Chen L; Placone J; Novicky L; Hristova K
    Sci Signal; 2010 Nov; 3(150):ra86. PubMed ID: 21119106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmembrane domain sequence requirements for activation of the p185c-neu receptor tyrosine kinase.
    Chen LI; Webster MK; Meyer AN; Donoghue DJ
    J Cell Biol; 1997 May; 137(3):619-31. PubMed ID: 9151669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strong dimerization of wild-type ErbB2/Neu transmembrane domain and the oncogenic Val664Glu mutant in mammalian plasma membranes.
    Placone J; He L; Del Piccolo N; Hristova K
    Biochim Biophys Acta; 2014 Sep; 1838(9):2326-30. PubMed ID: 24631664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of membrane protein interactions in plasma membrane derived vesicles with quantitative imaging Förster resonance energy transfer.
    Sarabipour S; Del Piccolo N; Hristova K
    Acc Chem Res; 2015 Aug; 48(8):2262-9. PubMed ID: 26244699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lead acetate induces EGFR activation upstream of SFK and PKCalpha linkage to the Ras/Raf-1/ERK signaling.
    Wang CY; Wang YT; Tzeng DW; Yang JL
    Toxicol Appl Pharmacol; 2009 Mar; 235(2):244-52. PubMed ID: 19133285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of dimerization efficiency of transmembrane domains in activation of fibroblast growth factor receptor 3.
    Volynsky PE; Polyansky AA; Fakhrutdinova GN; Bocharov EV; Efremov RG
    J Am Chem Soc; 2013 Jun; 135(22):8105-8. PubMed ID: 23679838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.